Approval to create a world-leading public health science campus

Richard Gleave, chief operating officer for PHE, reflects on this landmark decision Related items from OnMedica Brexit: what’s next for UK science and patients?National deal struck to boost medical science research Experts seek medical research prioritisation in Brexit talksPublic Health England plans ‘world-leading’ science campus Source: OnMedica

Revance will wait to seek backing for Botox-rival

(Reuters) – Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview. Source: Reuters Medical News

Obamacare sign-ups rise but overall enrollment set to fall

NEW YORK (Reuters) – The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program. Source: Reuters Medical News